FindTrial
Sign In

Evaluation of novel coronavirus pneumonia patients (COVID-19) treated with Chinese Medicine

Comparative study on novel coronavirus pneumonia strains in Henan during the same period

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200005898
Enrollment
Unknown
Registered
2022-04-23
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia

Interventions

Group 1:Traditional Chinese medicine and Western Medicine

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Novel coronavirus pneumonia patients were diagnosed. 2. Over 18 years old; 3. Voluntarily accept treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have not been treated with TCM syndrome differentiation or whose syndrome differentiation treatment is less than 3 days; 2. Dementia, various mental diseases and other patients with dementia who are unable to communicate.

Design outcomes

Primary

MeasureTime frame
transformation severe classification rate;Nucleic acid negative conversion rate;Nucleic acid negative time;—

Secondary

MeasureTime frame
Other;Disease outcome;CRP;routine blood test;Biochemical examination;D-dimer;Clinical symptom score;Safety index;Immunological examination;Heat retreat time;PCT;Chest imaging changes;—

Countries

China

Contacts

Public ContactLi Suyun, Cui Yinglin

The First Affiliated Hospital of Henan University of Chinese Medicine

lisuyun2000@126.com+86 0371 66248624

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026